US2023414861A1PendingUtilityA1
Compositions, devices and kits for selective internal radiation therapy
Est. expiryNov 1, 2039(~13.3 yrs left)· nominal 20-yr term from priority
A61M 5/007A61M 5/19A61M 5/3294A61M 5/1785A61K 51/1251A61K 51/1213A61N 2005/1098A61N 5/1007A61N 5/1031A61N 5/1027A61M 2205/583A61M 2210/1007A61J 1/2096A61N 2005/1021
73
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Systems, kits and methods for preparing an injection system and/or treating target lesions with a selective internal radiation therapy which includes a double-barrel syringe loaded with a two-component tissue glue and radioisotope loaded microspheres. The microspheres are loaded into the syringe based on the size of the target location and are administered with a needle or dual-lumen catheter. Dosing regimens for treating breast cancer lesions or surgical beds up to 130 mm in diameter and hepatocellular carcinoma lesions up to 50 mm are included.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method of preparing a therapy, comprising:
determining an average tumor size of a tumor lesion; selecting a 90 Y syringe activity level using the average tumor size; and loading a dual chamber syringe with the selected 90 Y syringe activity level, wherein the dual chamber syringe comprises a first chamber pre-loaded with bovine serum albumin and a second chamber pre-loaded with glutaraldehyde, wherein loading the dual chamber syringe comprises loading the 90 Y syringe activity level into the first and second chambers of the dual chamber syringe in a 4:1 ratio.Join the waitlist — get patent alerts
Track US2023414861A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.